UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
JAMA dermatology (Chicago, Ill.), ISSN 2168-6068, 02/2015, Volume 151, Issue 2, pp. 195 - 199
Life Sciences & Biomedicine | Dermatology | Science & Technology | Skin Neoplasms - drug therapy | Dermatomyositis - chemically induced | Skin Neoplasms - immunology | Humans | Ipilimumab | Middle Aged | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | CTLA-4 Antigen - immunology | Dermatomyositis - immunology | Immunity, Cellular - drug effects | Melanoma - immunology | Melanoma - drug therapy | Female | T-Lymphocytes - immunology | Dermatomyositis - pathology | Skin - pathology
Journal Article
Clinical rheumatology, ISSN 0770-3198, 11/2020, Volume 39, Issue 11, pp. 3195 - 3204
Life Sciences & Biomedicine | Rheumatology | Science & Technology | Arthritis, Psoriatic - epidemiology | Autoimmune Diseases - physiopathology | Glucocorticoids - therapeutic use | Undifferentiated Connective Tissue Diseases - epidemiology | Pandemics | Rheumatic Diseases - drug therapy | Arthritis, Psoriatic - physiopathology | Humans | Middle Aged | Coronavirus Infections - physiopathology | Male | Dermatomyositis - physiopathology | COVID-19 | Rheumatic Diseases - epidemiology | SARS-CoV-2 | Coronavirus Infections - epidemiology | Pneumonia, Viral - epidemiology | Arthritis, Rheumatoid - drug therapy | Dermatomyositis - drug therapy | Arthritis, Psoriatic - drug therapy | Scleroderma, Systemic - physiopathology | Lupus Erythematosus, Systemic - drug therapy | Sjogren's Syndrome - epidemiology | Spondylitis, Ankylosing - epidemiology | Aged, 80 and over | Betacoronavirus | Adult | Female | Arthritis, Rheumatoid - physiopathology | Autoimmune Diseases - drug therapy | Antirheumatic Agents - therapeutic use | Autoimmune Diseases - epidemiology | Lupus Erythematosus, Systemic - epidemiology | Sjogren's Syndrome - drug therapy | Spondylitis, Ankylosing - drug therapy | Arthritis, Rheumatoid - epidemiology | Dermatomyositis - epidemiology | Sjogren's Syndrome - physiopathology | Spondylitis, Ankylosing - physiopathology | Undifferentiated Connective Tissue Diseases - physiopathology | Scleroderma, Systemic - epidemiology | Pneumonia, Viral - physiopathology | Undifferentiated Connective Tissue Diseases - drug therapy | Rheumatic Diseases - physiopathology | Italy - epidemiology | Aged | Lupus Erythematosus, Systemic - physiopathology | Scleroderma, Systemic - drug therapy | Index Medicus
Journal Article
Journal of bone and mineral research, ISSN 0884-0431, 09/2015, Volume 30, Issue 9, pp. 1667 - 1675
GLUCOCORTICOIDS | BONE DENSITY | VERTEBRAL FRACTURES | RHEUMATIC DISORDERS | ADOLESCENTS | CHILDREN | rheumatic disorders | glucocorticoids | adolescents | children | vertebral fractures | bone density | Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | Glucocorticoids - therapeutic use | Lupus Erythematosus, Systemic - complications | Rheumatic Diseases - drug therapy | Scleroderma, Localized - complications | Humans | Male | Osteoporosis - drug therapy | Dermatomyositis - complications | Arthritis, Juvenile - drug therapy | Incidence | Systemic Vasculitis - complications | Dermatomyositis - drug therapy | Scleroderma, Systemic - complications | Lupus Erythematosus, Systemic - drug therapy | Female | Child | Glucocorticoids - adverse effects | Spinal Fractures - diagnosis | Scleroderma, Localized - drug therapy | Bone Density | Risk Factors | Proportional Hazards Models | Spinal Fractures - epidemiology | Systemic Vasculitis - drug therapy | Spinal Fractures - chemically induced | Adolescent | Arthritis, Juvenile - complications | Rheumatic Diseases - complications | Scleroderma, Systemic - drug therapy | Cohort Studies | Pediatrics | Fractures | Corticosteroids | Bones | Children | Health aspects | Density | Risk factors | Steroids | Vertebrae | Glucocorticoids | Spine (lumbar) | Prednisone | Patients | Radiography | Osteoporosis | Body mass index | Bone mineral density | Index Medicus
Journal Article
Clinics in dermatology, ISSN 0738-081X, 2015, Volume 34, Issue 3, pp. 344 - 352
Dermatology | Life Sciences & Biomedicine | Science & Technology | Lactation | Antiphospholipid Syndrome - drug therapy | Humans | Ultraviolet Therapy | Skin Diseases - drug therapy | Dermatologic Agents - therapeutic use | Dermatologic Agents - adverse effects | Scleroderma, Localized - therapy | Contraindications | Pregnancy Complications - drug therapy | Pregnancy | Skin Diseases - radiotherapy | Animals | Arthritis, Rheumatoid - drug therapy | Dermatomyositis - drug therapy | Lupus Erythematosus, Systemic - drug therapy | Female | Pemphigus - therapy | Pregnancy Complications - radiotherapy | Scleroderma, Systemic - drug therapy | Systemic scleroderma | Pregnant women | Scleroderma (Disease) | Index Medicus
Journal Article
Journal of drugs in dermatology, ISSN 1545-9616, 08/2012, Volume 11, Issue 8, pp. 979 - 987
Life Sciences & Biomedicine | Dermatology | Science & Technology | Pyoderma Gangrenosum - drug therapy | Psoriasis - drug therapy | Humans | Immunosuppressive Agents - therapeutic use | Skin Diseases - drug therapy | Prurigo - drug therapy | Sweet Syndrome - drug therapy | Cyclosporine - therapeutic use | Dermatitis, Atopic - drug therapy | Urticaria - drug therapy | Dermatomyositis - drug therapy | Lupus Erythematosus, Cutaneous - drug therapy | Chronic Disease
Journal Article
Annals of the rheumatic diseases, ISSN 0003-4967, 07/2011, Volume 70, Issue 7, pp. 1285 - 1288
Life Sciences & Biomedicine | Rheumatology | Science & Technology | Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis | Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy | Bone marrow, stem cells transplantation. Graft versus host reaction | Diseases of the osteoarticular system | Transfusions. Complications. Transfusion reactions. Cell and gene therapy | Biological and medical sciences | Medical sciences | Polymyositis - drug therapy | Creatine Kinase - blood | Follow-Up Studies | Humans | Male | Treatment Outcome | Biomarkers - blood | Polymyositis - physiopathology | Dermatomyositis - physiopathology | Mesenchymal Stem Cell Transplantation - adverse effects | Dermatomyositis - therapy | Mesenchymal Stem Cell Transplantation - methods | Young Adult | Pilot Projects | Dermatomyositis - drug therapy | Creatine Kinase, MB Form - blood | Adult | Female | Polymyositis - therapy | Muscle Strength | Drug Resistance | Treatment outcome | Polymyositis | Care and treatment | Patient outcomes | Dermatomyositis | Stem cells | Transplantation | Diagnosis | Research | Lung diseases | Mortality | Ulcers | Colleges & universities | Bone marrow | Family medical history | Umbilical cord | Drug resistance | Drug dosages | Patients | Growth factors | Index Medicus
Journal Article
Clinical rheumatology, ISSN 0770-3198, 4/2014, Volume 33, Issue 4, pp. 577 - 586
Steroid | Tumor necrosis factor-alpha-blocking agent | Disease-modifying anti-rheumatic drugs | Medicine & Public Health | Rheumatology | Hepatitis B | Rheumatic disease | Life Sciences & Biomedicine | Science & Technology | Azathioprine - therapeutic use | Lupus Erythematosus, Systemic - complications | Rheumatic Diseases - drug therapy | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Male | Spondylitis, Ankylosing - complications | Arthritis, Rheumatoid - complications | Dermatomyositis - complications | Young Adult | Arthritis, Rheumatoid - drug therapy | Dermatomyositis - drug therapy | Lupus Erythematosus, Cutaneous - drug therapy | Lupus Erythematosus, Systemic - drug therapy | Adult | Female | Virus Activation | Antiviral Agents - therapeutic use | Spondylitis, Ankylosing - drug therapy | Hepatitis B virus - physiology | Hepatitis B, Chronic - complications | Hepatitis B, Chronic - drug therapy | Adolescent | Rheumatic Diseases - complications | Aged | Lupus Erythematosus, Cutaneous - complications | Prednisone - therapeutic use | Cohort Studies | Hepatitis | Antiviral agents | Medical colleges | Care and treatment | Corticosteroids | Antirheumatic agents | Immunotherapy | Index Medicus | Case Based Review
Journal Article
Respiratory medicine, ISSN 0954-6111, 2012, Volume 106, Issue 4, pp. 581 - 587
Pulmonary/Respiratory | Rituximab | Polymyositis | Antisynthetase syndrome | Interstitial lung disease | Dermatomyositis | Cardiac & Cardiovascular Systems | Respiratory System | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Biological and medical sciences | Medical sciences | Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis | Respiratory system : syndromes and miscellaneous diseases | Pneumology | Glucocorticoids - therapeutic use | Follow-Up Studies | Autoantibodies - blood | Humans | Middle Aged | Drug Evaluation | Tomography, X-Ray Computed - methods | Male | Lung Diseases, Interstitial - diagnostic imaging | Treatment Failure | Female | Retrospective Studies | Lung Diseases, Interstitial - physiopathology | Drug Therapy, Combination | Myositis - drug therapy | Histidine-tRNA Ligase - immunology | B-Lymphocyte Subsets - drug effects | Creatine Kinase - blood | Respiratory Function Tests - methods | Treatment Outcome | Biomarkers - blood | Lung Diseases, Interstitial - drug therapy | Myositis - diagnostic imaging | Muscle, Skeletal - physiopathology | Immunologic Factors - adverse effects | Muscle Strength - drug effects | Antibodies, Monoclonal, Murine-Derived - adverse effects | Lymphocyte Depletion - methods | Myositis - physiopathology | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Immunologic Factors - therapeutic use | Antimitotic agents | Respiratory tract diseases | Care and treatment | Antineoplastic agents | Lung diseases | Disease | Raynaud disease | Medical treatment | Mortality | Cytotoxicity | Arthritis | Drug dosages | Steroids | Drugs | Computed tomography | Data processing | Prednisone | medical records | rituximab | Index Medicus
Journal Article
Clinical rheumatology, ISSN 0770-3198, 8/2018, Volume 37, Issue 8, pp. 2169 - 2178
Osteoporosis | Dickkopf-1 | Wnt signaling | Medicine & Public Health | Rheumatology | Sclerostin | Glucocorticoid | Life Sciences & Biomedicine | Science & Technology | Prednisolone - adverse effects | Glucocorticoids - administration & dosage | Prednisolone - administration & dosage | Prospective Studies | Dermatomyositis - blood | Humans | Middle Aged | Male | Bone Morphogenetic Proteins - blood | Lupus Erythematosus, Systemic - blood | Intercellular Signaling Peptides and Proteins - blood | Still's Disease, Adult-Onset - blood | Still's Disease, Adult-Onset - drug therapy | Dexamethasone - pharmacology | Dermatomyositis - drug therapy | Lupus Erythematosus, Systemic - drug therapy | Sjogren's Syndrome - blood | Adult | Female | Autoimmune Diseases - drug therapy | Glucocorticoids - adverse effects | Polymyositis - drug therapy | Vasculitis - blood | Bone Density | Sjogren's Syndrome - drug therapy | Japan | Bone Density Conservation Agents - therapeutic use | Wnt3A Protein - blood | Biomarkers - blood | Genetic Markers | Prednisolone - pharmacology | Autoimmune Diseases - blood | Polymyositis - blood | Wnt Signaling Pathway - drug effects | Vasculitis - drug therapy | Glucocorticoids - pharmacology | Medical colleges | Phosphatases | Corticosteroids | Peptides | RNA | Collagen | Autoimmune diseases | Steroids | Alkaline phosphatase | Collagen (type I) | Wnt protein | Glucocorticoids | SOST protein | Phosphatase | Osteoblasts | Proteins | β-catenin | Signal transduction | Bone growth | Vitamin D | Prednisolone | Enzyme-linked immunosorbent assay | Procollagen | Dexamethasone | Gene expression | Patients | Serum levels | Polymerase chain reaction | Acid phosphatase (tartrate-resistant) | Dkk1 protein | Osteogenesis | Index Medicus
Journal Article